• Journal of Korean Neurosurgical Society
• /
• 제48권6호
• /
• pp.501-505
• /
• 2010

Objective : This study was undertaken to compare the diagnostic performances of magnetic resonance imaging (MRI), MR myelography (MRM) and myelography in young soldiers with a herniated lumbar disc (HLD). Methods : Sixty-five male soldiers with HLD comprised the study cohort. A visual analogue scale for low back pain (VAS-LBP), VAS for leg radiating pain (VAS-LP), and Oswestry disability index (ODI) were applied. Lumbar MR, MRM, and myelographic findings were checked and evaluated by four independent radiologists, respectively. Each radiologist was asked to score (1 to 5) the degree of disc protrusion and nerve root compression using modified grading systems devised by the North American Spine Society and Pfirrmann and the physical examination rules for conscription in the Republic of Korea. Correlated coefficients between clinical and radiological factors were calculated. Interpretational reproducibility between MRI and myelography by four bases were calculated and compared. Results : Mean patient age was $20.5{\pm}1.1$. Mean VAS-LBP and VAS-LP were $6.7{\pm}1.6$ and $7.4{\pm}1.7$, respectively. Mean ODI was $48.0{\pm}16.2%$. Mean MRI, MRM, and myelography scores were $3.3{\pm}0.9$, $3.5{\pm}1.0$, and $3.9{\pm}1.1$, respectively. All scores of diagnostic performances were significantly correlated (p < 0.05). However, none of these scores reflected the severity of patients' symptoms. There was no statistical difference of interpretational reproducibility between MRI and myelography. Conclusion : Although MRI and myelography are based on different principles, they produce similar interpretational reproducibility in young soldiers with a HLD. However, these modalities do not reflect the severity of symptoms.

• Radiation Oncology Journal
• /
• 제29권3호
• /
• pp.199-205
• /
• 2011

Purpose: The present study compared the difference between intraoperative transrectal ultrasound (iTRUS)-based prostate volume and preplan computed tomography (CT), preplan magnetic resonance imaging (MRI)-based prostate volume to estimate the number of seeds needed for appropriate dose coverage in permanent brachytherapy for prostate cancer. Materials and Methods: Between March 2007 and March 2011, among 112 patients who underwent permanent brachytherapy with $^{125}I$, 60 image scans of 56 patients who underwent preplan CT (pCT) or preplan MRI (pMRI) within 2 months before brachytherapy were retrospectively reviewed. Twenty-four cases among 30 cases with pCT and 26 cases among 30 cases with pMRI received neoadjuvant hormone therapy (NHT). In 34 cases, NHT started after acquisition of preplan image. The median duration of NHT after preplan image acquisition was 17 and 21 days for cases with pCT and pMRI, respectively. The prostate volume calculated by different modalities was compared. And retrospective planning with iTRUS image was performed to estimate the number of $^{125}I$ seed required to obtain recommended dose distribution according to prostate volume. Results: The mean difference in prostate volume was 9.05 mL between the pCT and iTRUS and 6.84 mL between the pMRI and iTRUS. The prostate volume was roughly overestimated by 1.36 times with pCT and by 1.33 times with pMRI. For 34 cases which received NHT after image acquisition, the prostate volume was roughly overestimated by 1.45 times with pCT and by 1.37 times with pMRI. A statistically significant difference was found between preplan image-based volume and iTRUS-based volume (p<0.001). The median number of wasted seeds is approximately 13, when the pCT or pMRI volume was accepted without modification to assess the required number of seeds for brachytherapy. Conclusion: pCT-based volume and pMRI-based volume tended to overestimate prostate volume in comparison to iTRUS-based volume. To reduce wasted seeds and cost of the brachytherapy, we should take the volume discrepancy into account when we estimate the number of $^{125}I$ seeds for permanent brachytherapy.

• Investigative Magnetic Resonance Imaging
• /
• 제17권2호
• /
• pp.133-143
• /
• 2013

목적 : 직결장암 조직의 자기공명영상과 고주파 초음파검사를 시행한 후 종양의 탐지와 침윤 깊이에 대해 각각의 영상 소견과 병리 소견을 비교하여 진단적 정확도를 두 영상 기기 간 비교하고, 자기공명영상의 경우 종양의 침윤 깊이를 주변 정상 조직과 가장 명확히 보여주는 펄스 연쇄 (pulse sequence)에 대해 알아보았다. 대상 및 방법 : 직결장암으로 절제술을 시행한 45명의 환자에서 얻은 45예의 제거된 종양 조직을 수조에 넣고 생리 식염수에 담가서 고주파수 (5-17 MHz)의 선형 탐촉자를 이용하여 초음파영상을 얻었으며 8-channel 두경부 코일에 넣어 자기공명영상을 얻었다. 이 연구에 대하여 기관감사위원회의 공지에 입각한 동의는 면제되었다. 자기공명영상은 정- 및 탈위상 경사에코 T1 강조영상, 급속스핀에코 T2 강조영상 및 이의 지방억제 영상, fast imaging employing steady-state acquisition (FIESTA)와 이의 지방억제영상, 확산강조영상 등 일곱 가지 펄스 연쇄를 시행하였다. 각 조직의 자기공명영상과 초음파영상 소견을 각각 독립적으로 종양의 탐지와 침윤 깊이에 대하여 두 명의 영상의학과 의사가 합의 하에 평가하였고 각각의 영상 소견을 병리 조직 소견과 비교하여 두 영상 기기 간 진단적 정확도를 비교하였다. 자기공명영상의 일곱 가지 펄스 연쇄 중에 종양의 침윤 깊이를 주변 정상 조직과 구분하여 명확히 보여주는 펄스 연쇄에 대해 알아보았다. 결과 : 직결장암 조직의 종양 탐지와 침윤 깊이를 평가하는데 있어 자기공명영상과 초음파의 진단적 정확도는 각각 91.1%와 86.7%로 높게 나타났다. 조기 직결장암의 경우 초음파 검사의 정확도는 87.5%, 자기공명영상 검사의 정확도는 75.0%로 나왔다. 두 영상 기기 간에 통계적으로 유의한 차이는 없었다 (p > 0.05). MR의 펄스 연쇄 중에 종양의 침윤 깊이를 주변 정상 조직과 구분하여 명확하게 보여주는 영상은 직결장암 및 조기 직결장암 모두 급속 스핀에코 T2 강조영상이었다. 결론 : 자기공명영상과 초음파 검사는 직결장암 조직의 종양 탐지와 침윤 깊이를 평가하는데 높은 진단적 정확도를 가지고 있으며, 자기공명영상의 급속스핀에코 T2 강조영상이 직결장암 조직의 종양 침윤 깊이를 평가하는데 가장 우수하였다.

• 대한핵의학회지
• /
• 제37권4호
• /
• pp.229-234
• /
• 2003

목적: 홍역 감염 후 속발되는 뇌염은 사망률이 높아 조기진단 및 적극적인 치료가 예후에 중요하다. 저자들은 홍역 후 발생된 뇌염에 대한 Tc-99m ECD 뇌혈류 SPECT와 뇌핵자기공명영상(MRI)의 진단 성능을 비교하였고 뇌혈류 SPECT상 중등도 이상의 심한 뇌혈류 감소가 호발하는 부위를 알아보았다. 대상 및 방법: 홍역으로 진단받은 112명 중에서 의식저하, 경련, 마비 등의 임상증상과 혈청 및 뇌척수액에서 홍역 특이항체가 관찰되어 홍역 후 급성 뇌염으로 진단받고 Tc-99m ECD 뇌혈류 SPECT와 MRI를 시행받은 11명(M : F=4 : 7, 연령 $1.6{\sim}14$세)을 대상으로 하였다. SPECT상 관찰되는 뇌혈류는 0(정상)에서 3(결손)으로 점수화하였고 2점 이상인 경우를 중등도 뇌혈류 감소로 정의하였다. 홍역 후 발생된 뇌염 환아에서 MRI와 SPECT의 두부병소 진단 성능과 중등도 뇌혈류 감소의 호발부위를 알아보았다. 결과: MRI 시행결과 7명(63.6%)에서 T2-강조영상에서 회백질의 고강도 변화가 관찰되었으나, SPECT상 11명(100%) 모두에서 뇌혈류 감소 부위가 관찰되었다. 중등도 뇌혈류 감소는 전두엽(81.8%), 측두엽(72.7%), 후두엽(27.3%), 기저핵(27.3%), 두정엽(9.1%) 순서로 호발하였다. 결론: 홍역 후 발생된 뇌염 환아에서 두부병소를 진단하는데 MRI에 비하여 Tc-99m ECD 뇌혈류 SPECT가 좀더 도움이 될 것으로 사료된다.

• Nuclear Medicine and Molecular Imaging
• /
• 제42권sup1호
• /
• pp.101-109
• /
• 2008

Cervix cancer is one of common gynecological cancers in the world, and staged with FIGO or TNM system. However, these clinical staging systems lack information about lymph node or distant metastases, thus imaging modalities are considered to make an appropriate therapeutic plan and enhance overall survival rate. In this context, FDG PET is recommended to pre-treatment stating and prognosis prediction, for it could noninvasively evaluate the status of lymph nodes, especially abdominal paraaortic nodes which are closely related with prognosis. Moreover, the degree of FDG uptake is correlated with prognosis. Although there is no consistent method for surveillance of cervix cancer, FDG PET seems a very important tool in detecting tumor recurrence because it is much more advantageous than conventional imaging modalities such as MRI for discerning recurrent tumor from fibrosis caused by radiation or surgery. Furthermore, FDG PET could be used to evaluate treatment response. On the other hand, recently introduced PET/CT is expected to play an ancillary role to FIGO staging by adding anatomical information, and enhance diagnostic performance of PET by decreasing false positive findings.

• Biomolecules & Therapeutics
• /
• 제26권1호
• /
• pp.81-92
• /
• 2018

It is widely accepted that altered metabolism contributes to cancer growth and has been described as a hallmark of cancer. Our view and understanding of cancer metabolism has expanded at a rapid pace, however, there remains a need to study metabolic dependencies of human cancer in vivo. Recent studies have sought to utilize multi-modality imaging (MMI) techniques in order to build a more detailed and comprehensive understanding of cancer metabolism. MMI combines several in vivo techniques that can provide complementary information related to cancer metabolism. We describe several non-invasive imaging techniques that provide both anatomical and functional information related to tumor metabolism. These imaging modalities include: positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS) that uses hyperpolarized probes and optical imaging utilizing bioluminescence and quantification of light emitted. We describe how these imaging modalities can be combined with mass spectrometry and quantitative immunochemistry to obtain more complete picture of cancer metabolism. In vivo studies of tumor metabolism are emerging in the field and represent an important component to our understanding of how metabolism shapes and defines cancer initiation, progression and response to treatment. In this review we describe in vivo based studies of cancer metabolism that have taken advantage of MMI in both pre-clinical and clinical studies. MMI promises to advance our understanding of cancer metabolism in both basic research and clinical settings with the ultimate goal of improving detection, diagnosis and treatment of cancer patients.

• Archives of Plastic Surgery
• /
• 제32권6호
• /
• pp.796-797
• /
• 2005

In plastic and reconstructive craniomaxillofacial surgery, careful preoperative planning is essential to get a successful outcome. Many craniomaxillofacial surgeons have used imaging modalities like conventional radiographs, computed tomography(CT) and magnetic resonance imaging(MRI) for supporting the planning process. But, there are a lot of limitations in the comprehension of the surgical anatomy with these modalities. Medical models made with rapid prototyping (RP) technique represent a new approach for preoperative planning and simulation surgery. With rapid prototyping models, surgical procedures can be simulated and performed interactively so that surgeon can get a realistic impression of complex structures before surgical intervention. The great advantage of rapid prototyping technique is the precise reproduction of objects from a 3-dimensional reconstruction image as a physical model. Craniomaxillofacial surgeon can establish treatment strategy through preoperative simulation surgery and predict the postoperative result.

• Radiation Oncology Journal
• /
• 제36권2호
• /
• pp.114-121
• /
• 2018

Purpose: To explore the feasibility of maximum diameter as a response assessment method for vestibular schwannomas (VS) after stereotactic radiosurgery or fractionated stereotactic radiotherapy (RT), we analyzed the concordance of RT responses between maximum diameters and volumetric measurements. Materials and Methods: Forty-two patients receiving curative stereotactic radiosurgery or fractionated stereotactic RT for VS were analyzed retrospectively. Twelve patients were excluded: 4 did not receive follow-up magnetic resonance imaging (MRI) scans and 8 had initial MRI scans with a slice thickness >3 mm. The maximum diameter, tumor volume (TV), and enhanced tumor volume (ETV) were measured in each MRI study. The percent change after RT was evaluated according to the measurement methods and their concordances were calculated with the Pearson correlation. The response classifications were determined by the assessment modalities, and their agreement was analyzed with Cohen kappa statistics. Results: Median follow-up was 31.0 months (range, 3.5 to 86.5 months), and 90 follow-up MRI studies were analyzed. The percent change of maximum diameter correlated strongly with TV and ETV (r(p) = 0.85, 0.63, p = 0.000, respectively). Concordance of responses between the Response Evaluation Criteria in Solid Tumors (RECIST) using the maximum diameters and either TV or ETV were moderate (kappa = 0.58; 95% confidence interval, 0.32-0.85) or fair (kappa = 0.32; 95% confidence interval, 0.05-0.59), respectively. Conclusions: The percent changes in maximum diameter and the responses in RECIST were significantly concordant with those in the volumetric measurements. Therefore, the maximum diameters can be used for the response evaluation of VS following stereotactic RT.

• Korean Journal of Radiology
• /
• 제22권8호
• /
• pp.1369-1378
• /
• 2021

Objective: Few attempts have been made to investigate the prognostic value of dynamic contrast-enhanced (DCE) MRI or dynamic susceptibility contrast (DSC) MRI of non-enhancing, T2-high-signal-intensity (T2-HSI) lesions of glioblastoma multiforme (GBM) in newly diagnosed patients. This study aimed to investigate the prognostic values of DCE MRI and DSC MRI parameters from non-enhancing, T2-HSI lesions of GBM. Materials and Methods: A total of 76 patients with GBM who underwent preoperative DCE MRI and DSC MRI and standard treatment were retrospectively included. Six months after surgery, the patients were categorized into early progression (n = 15) and non-early progression (n = 61) groups. We extracted and analyzed the permeability and perfusion parameters of both modalities for the non-enhancing, T2-HSI lesions of the tumors. The optimal percentiles of the respective parameters obtained from cumulative histograms were determined using receiver operating characteristic (ROC) curve and univariable Cox regression analyses. The results were compared using multivariable Cox proportional hazards regression analysis of progression-free survival. Results: The 95th percentile value (PV) of Ktrans, mean Ktrans, and median Ve were significant predictors of early progression as identified by the ROC curve analysis (area under the ROC curve [AUC] = 0.704, p = 0.005; AUC = 0.684, p = 0.021; and AUC = 0.670, p = 0.0325, respectively). Univariable Cox regression analysis of the above three parametric values showed that the 95th PV of Ktrans and the mean Ktrans were significant predictors of early progression (hazard ratio [HR] = 1.06, p = 0.009; HR = 1.25, p = 0.017, respectively). Multivariable Cox regression analysis, which also incorporated clinical parameters, revealed that the 95th PV of Ktrans was the sole significant independent predictor of early progression (HR = 1.062, p < 0.009). Conclusion: The 95th PV of Ktrans from the non-enhancing, T2-HSI lesions of GBM is a potential prognostic marker for disease progression.

• Korean Journal of Radiology
• /
• 제24권10호
• /
• pp.983-995
• /
• 2023

Objective: To compare the diagnostic performance and interobserver agreement between contrast-enhanced computed tomography (CECT) and contrast-enhanced magnetic resonance imaging (CE-MRI) with magnetic resonance cholangiopancreatography (MRCP) for evaluating the resectability in patients with extrahepatic cholangiocarcinoma (eCCA). Materials and Methods: This retrospective study included treatment-naïve patients with pathologically confirmed eCCA, who underwent both CECT and CE-MRI with MRCP using extracellular contrast media between January 2015 and December 2020. Among the 214 patients (146 males; mean age ± standard deviation, 68 ± 9 years) included, 121 (56.5%) had perihilar cholangiocarcinoma. R0 resection was achieved in 108 of the 153 (70.6%) patients who underwent curative-intent surgery. Four fellowship-trained radiologists independently reviewed the findings of both CECT and CE-MRI with MRCP to assess the local tumor extent and distant metastasis for determining resectability. The pooled area under the receiver operating characteristic curve (AUC), sensitivity, and specificity of CECT and CE-MRI with MRCP were compared using clinical, surgical, and pathological findings as reference standards. The interobserver agreement of resectability was evaluated using Fleiss kappa (κ). Results: No significant differences were observed between CECT and CE-MRI with MRCP in the pooled AUC (0.753 vs. 0.767), sensitivity (84.7% [366/432] vs. 90.3% [390/432]), and specificity (52.6% [223/424] vs. 51.4% [218/424]) (P > 0.05 for all). The AUC for determining resectability was higher when CECT and CE-MRI with MRCP were reviewed together than when CECT was reviewed alone in patients with discrepancies between the imaging modalities or with indeterminate resectability (0.798 [0.754-0.841] vs. 0.753 [0.697-0.808], P = 0.014). The interobserver agreement for overall resectability was fair for both CECT (κ = 0.323) and CE-MRI with MRCP (κ = 0.320), without a significant difference (P = 0.884). Conclusion: CECT and CE-MRI with MRCP showed no significant differences in the diagnostic performance and interobserver agreement in determining the resectability in patients with eCCA.